Pathogenetic substantiation for plasmapheresis application in the treatment of chronic heart failure

Close metadata

Recommended articles:

Off-pump coronary artery bypass surgery in patients with multifocal atherosclerosis and inoperable internal carotid artery lesion. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(3):253-257

Prediction of myocardial contractility after coronary bypass surgery according to preoperative contrast-enhanced magnetic resonance imaging and echocardiography. Pirogov Russian Journal of Surgery. 2024;(4):75-81

Fifteen-year results of bilateral and unilateral internal mammary artery grafting. Pirogov Russian Journal of Surgery. 2024;(5):51-57

Preventive myocardial revascularization prior to abdominal aortic repair in patients without cardiac symptoms: long-term results. Pirogov Russian Journal of Surgery. 2024;(5):58-64

Helium-induced preconditioning and postconditioning in patients with myocardial ischemia. Russian Cardiology Bulletin. 2024;(2):5-12

Cardiotropic effect of natural nitric oxide donor in doxorubicin cardiomyopathy. Russian Cardiology Bulletin. 2024;(2):27-31

Left ventricular reverse remodeling after transcatheter mitral valve repair in a patient with ischemic cardiomyopathy. Russian Cardiology Bulletin. 2024;(2):72-80

Assessment of patient satisfaction during therapeutic plasmapheresis. Russian Journal of Preventive Medicine. 2024;(5):46-52

Impact of SGLT2 inhibitors on erythropoiesis and iron exchange in patients with diabetes mellitus and chronic heart failure. Russian Journal of Preventive Medicine. 2024;(5):103-110

Double-tract reconstruction after gastrectomy for gastric cancer in patients with concomitant cardiovascular diseases. Pirogov Russian Journal of Surgery. 2024;(6):58-69

Keywords:

coronary heart disease

chronic heart failure

plasmapheresis

blood rheology

hemostasis system

Authors:

Mal'chevskiĭ Iu.E.

Institut meditsinskikh problem Severa SO RAMN, Krasnoiarsk;
kafedra klinicheskoĭ transfuziologii IPO Pervogo MGMU im. I.M. Sechenova

Ragimov A.A.

Institut meditsinskikh problem Severa SO RAMN, Krasnoiarsk;
kafedra klinicheskoĭ transfuziologii IPO Pervogo MGMU im. I.M. Sechenova

Belov Yu.V.

RNTsKh im. akad. B.V. Petrovskogo RAMN

SPIN RSCI: 2740-1439
Scopus AuthorID: 7101862336
ResearcherID: 7101862336
ORCID: 0000-0002-9280-8845

List of references:

Аgeev F.T. EHvolyutsiya predstavlenij o diastolicheskoj funktsii serdtsa [The evolution of ideas about the diastolic function of the heart]. Serdechnaya nedostatochnost' 2000; 2: 48-50. (In Russian)
Belenkov YU.N., Privalova E.V., CHekneva I.S. Mozgovoj natrijureticheskij peptid - sovremennyj biomarker khronicheskoj serdechnoj nedostatochnosti [Brain natriuretic peptide - a modern biomarker of chronic heart failure]. Kardiologiya 2008; 6:62-69. (In Russian)
Belousov YU.B. Kliniko-patogeneticheskie aspekty vnutrisosudistoj koagulyatsii i reologicheskikh narushenij u bol'nykh ishemicheskoj bolezn'yu serdtsa [Clinical and pathogenetic aspects of intravascular coagulation and rheological disorders in patients with coronary heart disease]: Аvtoref. dis. … d-ra med. nauk. M 1982. (In Russian)
Vasyuk YU.А. Ishemicheskij kaskad i vozmozhnost' miokardial'noj tsitoprotektsii [Ischemic cascade and the possibility of myocardial cytoprotection]. Rossijskij nauchnyj forum s mezhdunarodnym uchastiem "Kardiologiya", 3-j: Materialy. M 2001; 5. (In Russian)
Galyavich А.S., Meryasev S.N., Galyavi R.А., Meryaseva R.F. N-termal'nyj pro-mozgovoj natrijureticheskij peptid I vyzhivaemost' bol'nykh khronicheskoj serdechnoj nedostatoch-
Glezer M.G. Kombinatsiya Koraksana s beto-adrenoblokatorami: situatsii, kogda ehta strategiya opravdana [Coraxan with Beto-blockers combination: a situation where this strategy is justified]. M: Kompaniya Medikom 2009; 16. (In Russian)
Godulyan А.V. Metabolicheskaya i gormonal'naya korrektsiya u bol'nykh ishemicheskoj bolezn'yu serdtsa v sochetanii s sakharnym diabetom 2-go tipa, pod vliyaniem plazmafereza i lazeroterapii [Metabolic and hormonal correction in patients with coronary heart disease combined with diabetes mellitus type 2, under the influence of laser therapy and plasmapheresis]: Аvtoref. dis. … kand. med. nauk. M 2002. (In Russian)
Doyutova M.V., Guseva N.K. Potrebnost' v mediko-sotsial'nykh meropriyatiyakh otdel'nykh kategorij lits starshej vozrastnoj gruppy [The need for medical and social activities of certain categories of older persons]. Klin gerontol 2009; 12: 33-36. (In Russian)
Drapkina O.M., Bueverova E.L., Ivashkin V.T. Izolirovannaya sistolicheskaya arterial'naya gipertenziya u pozhilykh bol'nykh. Ros med vest 2008; 13: 1: 3-10. (In Russian)
Kalyuzhin V.V., Kalyuzhin O.V., Teplyakov А.T., Karaulov А.V. KHronicheskaya serdechnaya nedostatochnost' [Chronic heart failure]. M: MIА 2006. (In Russian)
Larina V.N., Bart B.YA., Dergunova E.N., Аlieva Z.I. KHronicheskaya serdechnaya nedostatochnost' v pozhilom vozraste: klinicheskoe techenie i prognoz v zavisimosti ot funktsional'nogo sostoyaniya levogo zheludochka [Chronic heart failure in the elderly: clinical course and prognosis depending on the functional state of the left ventricle]. Serdechnaya nedostatochnost' 2012; 2. (In Russian)
Lyusov V.А., Belousov YU.B., Parfenov А.S. Аktual'nye problemy gemostaziologii [Actual problems of Hemostasis]. M 1979; 140-146. (In Russian)
Mareev V.YU., Belenkov YU.N. Perspektivy v lechenii khronicheskoj serdechnoj nedostatochnosti [Perspectives in the treatment of chronic heart failure]. Serdechnaya nedostatochnost' 2002; 3: 109-114. (In Russian)
Postnikov А.А., Model S.V., Bozh'ev А.А. i dr. Koagulologicheskie i gemoreologicheskie mekhanizmy lechebnoj ehffektivnosti plazmafereza u bol'nykh ishemicheskoj bolezn'yu serdtsa [Coagulologic and hemorheological mechanisms of therapeutic efficacy of plasma exchange in patients with coronary heart disease] // Mat. Pervoj Vserossijskaya nauchnaya konferentsiya "Klinicheskaya gemostaziologiya i gemoreologiya v serdechnoosudistoj khirurgii", 1-ya: Materialy. M 2003. (In Russian)
Solov'eva I.N., Ragimov А.А., Mikhajlov YU.E. i dr. Plazmaferez pri ishemicheskoj bolezni serdtsa: da ili net? [Plasmapheresis in coronary heart disease: yes or no?] EHfferentnaya i fiziko-khim med 2012; 3: 30-37. (In Russian)
Firsov N.N., Dzhanashiya P.KH. Vvedenie v ehksperimental'nuyu i klinicheskuyu gemoreologiyu [Introduction to experimental and clinical hemorheology]. M: Izd-vo RGMU 2008; 274. (In Russian)
CHazov E.I. Puti snizheniya smertnosti ot serdechno-sosudistykh zabolevanij [Ways to reduce the cardiovascular death rate]. Ter arkh 2008; 8: 11-16. (In Russian)
Ahmed A. Chronic heart failure in older adults. Med Clin North Am 2011; 95: 3: 439-461.
Agnoletti L., Curello S., Bachetti T. et al. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. Circulation 1999; 100: 1983-1991.
Annweiler C., Bataille R., Ferrière N. et al. Plasma beta-2 microglobulin as a marker of frailty in older adults: a pilot study. J Gerontol Biol Sci Med Sci 2011; 66: 10: 1077-1079.
Baskurt O.K. In vivo correlates of altered blood rheology. Biorheology 2008; 45: 6: 629-638.
Cesari F., Caporale R., Marcucci R. et al. NT-proBNP and the anti-inflammatory cytokines are correlated with endothelial progenitor cells' response to cardiac surgery. Atherosclerosis 2008; 199: 1: 138-146.
Danesh J., Lewington S. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant metaanalysis. JAMA 2005; 294: 14: 1799-1809.
Doehner W., Bunck A.C., Rauchhaus M. et al. Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. Eur Heart J 2007; 28: 821-828.
Force T.L. Heart failure: molecules, mechanisms and therapeutic targets. Circulation 2007; 115: 347.
Freeman C. Evidence-based guideline update: plasmapheresis in neurologic disorders. Neurology 2011; 77: 17: 105.
Gao W.Q., Ma J.L., Han C.G. et al. Lymphocyte GRK2 expression of the very elderly with chronic heart failure. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2010; 26: 2: 207-209.
Keсeligil H.T., Bahcivan M., Demirag M.K. et al. Principles for the treatment of cardiac injuries: a twenty-two year experience. Ulus Travma Acil. Cerrahi Derg 2009; 15: 2: 171-175.
Leinonen M., Linnanmaki E., Mattila K. et al. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog 1990; 9: 67-73.
Leschke M. Rheology and coronary heart disease. Dtsch Med Wochenschr 2008; 133: 8: 270-273.
Marossy A., Svorc P., Kron I., Gresová S. Hemorheology and circulation. Clin Hemorheol Microcirculat 2009; 42: 4: 239-258.
Owen-Lynch P.J. Analyzing the oscillatory components of the dynamics of blood flow. J Appl Physiol 2008; 105: 1: 374.
Potvin O., Forget H., Praville M. et al. Relationship between cortisol level and prevalent/incident cognitive impairment and its moderating factors in older adults. Int Psychogeriatr 2013; 25: 2: 252-262.
Pusey C.D., Levy J.B. Plasmapheresis in immunologic renal disease. Blood Purif 2012; 33: 1-3: 190-198.
Reggiori G., Occhipinti G., De Gasperi A. et al. Early alterations of red blood cell rheology in critically ill patients. Crit Care Med 2009; 37: 12: 3041-3046.
Salomaa V., Rasi V., Kulathinal S. et al. Hemostatic factors as predictors of coronary events and total mortality: the FINRISK '92 Hemostasis Study. Arterioscler Thrombos Vasc Biol 2002; 22: 353-358.
Sanderson J.E. Heart failure with a normal ejection fraction. Heart 2007; 93: 155-158.
Zhao L., Wang B., You G. et al. Effects of different resuscitation fluids on the rheologic behavior of red blood cells, blood viscosity and plasma viscosity in experimental hemorrhagic shock. Resuscitation 2009; 80: 2: 253-258.

Close metadata